https://www.prnewswire.com/apac/news-releases/shiratronics-announces-positive-12-month-follow-up-results-from-reliev-cm-pilot-study-demonstrating-sustained-clinical-benefit-with-investigational-implantable-neuromodulation-therapy-for-chronic-migraine-302555432.html

ShiraTronics Announces Positive 12-Month Follow-Up Results from RELIEV-CM Pilot Study, Demonstrating Sustained Clinical Benefit with Investigational Implantable Neuromodulation Therapy for Chronic Migraine